Navigation Links
Economic Growth To Continue Throughout 2013
Date:4/30/2013

their organizations worldwide.

The full text version of the reports is posted on ISM's Home Page at www.ism.ws on the first and third business day of every month after 10:10 a.m. (ET).

The next Manufacturing ISM Report On Business® featuring the April 2013 data will be released at 10:00 a.m. (ET) on Wednesday, May 1, 2013.

The next Non-Manufacturing ISM Report On Business® featuring the April 2013 data will be released at 10:00 a.m. (ET) on Friday, May 3, 2013.Contact:Rose Marie GoupilISM, ROB Media RelationsTempe, Arizona(800) 888-6276, ext. 3015email: rgoupil@ism.ws(Logo:  http://photos.prnewswire.com/prnh/20121101/LA02871LOGO)


'/>"/>
SOURCE Institute for Supply Management
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology news :

1. U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care
2. NRELs economic benefit to Colorado totals $814.8 million in FY 2012
3. New whole plant therapy shows promise as an effective and economical treatment for malaria
4. New health-economic model shows benefits of boosting dietary calcium intake
5. Texas Biomed reports faster, more economical method for detecting bioterror threats
6. Global economic pressures trickle down to local landscape change, altering disease risk
7. Molecular economics: New computer models calculate systems-wide costs of gene expression
8. Study shows economic feasibility for capturing carbon dioxide directly from the air
9. An economical, effective and biocompatible gene therapy strategy promotes cardiac repair
10. Scientific meeting at Virginia Tech will make more than $2 million economic impact
11. Socioeconomics may affect toddlers exposure to flame retardants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... 24, 2015 Research and Markets ... the "Global 2D Gesture Recognition Market 2015-2019" ... The analysts forecast the Global 2D Gesture Recognition ... over the period 2014-2019 The increased ... is one of the major trends in the ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
... Bioinformatics Institute at Virginia Tech have assembled the draft ... across the US in a project that aims to ... The results have been published in Nature Communications. ... fuel sources to prevent a potential energy crisis and ...
... BIOLOGY -- When neutrons and simulation unite . . ... workhorses of the cellular world, could become easier by ... in Biophysical Journal. A team led by Oak Ridge ... high-performance computer simulation and a type of neutron analysis ...
... EAST LANSING, Mich. For children with autism, being ... to increase the severity of their symptoms, according to ... autistic children who were born either preterm or post-term ... children born on time, revealed the study by Tammy ...
Cached Biology News:April 2012 story tips 2April 2012 story tips 3April 2012 story tips 4Autistic kids born preterm, post-term have more severe symptoms 2
(Date:3/4/2015)... 2015  BioClinica®, Inc., a leading specialty ... announced that clinical trial professionals representing 20 ... annual European User Conference in ... use of its eClinical technologies to overcome ... the Microsoft Office-Smart OnPoint CTMS; Express EDC; ...
(Date:3/4/2015)... March 4, 2015 Launched ... Paris in December 2011, ,SARAH, - ... resin microspheres versus sorafenib in advanced hepatocellular carcinoma (HCC) ... 2016.   SARAH, a large French study ... carcinoma, or HCC) has completed patient enrolment, exceeding its ...
(Date:3/3/2015)... 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, ... molecular diagnostics that target the underlying mechanisms of cancer, ... period ended December 31, 2014. Effective July ... from May 31 to December 31. As a result ... are for the quarter and the seven months ended ...
(Date:3/3/2015)... 03, 2015 Experts and industry insiders ... one event: the Alltech REBELation exploring innovation, inspiration and ... Now in its 31st year, Alltech’s annual international conference ... and the opportunity to join the REBELation at an ... 11:59 p.m. EST, at which point the standard early ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... PRINCETON, N.J., Oct. 26 Pharmasset, Inc.,(Nasdaq: VRUS ) management ... -- Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference ... the New York Palace Hotel in New York ... Officer, will provide an overview of the company ...
... Bionovo, Inc.,(Nasdaq: BNVI ) (the "Company") today announced that ... stock at a price to the public of,$2.50 per share ... per share at a price of $0.10 per warrant. The ... up to an additional 15% of,the offering to cover over-allotments. ...
... Call for Patient Group Task Force to Fight ... the views of bodies that,represent more than 121,000 ... - one of the world,s biggest net exporters ... for patient,groups across Europe to unite to battle ...
Cached Biology Technology:Pharmasset to Present at Three Investor Conferences in November 2007 2Bionovo Announces the Pricing of Public Offering of Shares of Common Stock 2Bionovo Announces the Pricing of Public Offering of Shares of Common Stock 3Patients Fail to Take Fake Medicines Risk Seriously 2Patients Fail to Take Fake Medicines Risk Seriously 3
... is a fluorescent nucleic acid dye which ... As a nuclear counterstain, propidium iodide stains ... color. The fluorescent red color provides ... such as FITC, Cy2 or AMCA. ...
... cultured in DMEM and harvested at the log ... the antigens in their native forms, cells were ... on a 12-well (5 mm) adhesive coated slide, ... cellular attachment and to minimize background staining. ...
...
... Application: Acridine orange has been used as ... agarose and polyacrylamide gels. Acridine orange at ... purified DNA in gels with a sensitivity ... also been used extensively for cell staining ...
Biology Products: